Congress funds cancer screening for uninsured women through 2030

What it does

This bill reauthorizes and expands the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), a federal program that provides free or low-cost cancer screening and diagnostic services to uninsured and underinsured women. The bill funds the program at $235 million annually through 2030, broadens its mission to include prevention and health equity, and requires the Government Accountability Office to study program reach and barriers to access by September 2027.

Why we flagged it

The bill's core function is straightforward: reauthorize and expand a federal cancer-screening program for underserved populations. It is a routine public-health measure with no hidden mechanisms or narrow beneficiaries.

What the text implies

• Shift from 'detection and control' to 'prevention, detection, and control' expands program scope beyond screening into prevention education and outreach—a modest scope creep but aligned with public health.
• Reporting requirement changes from annual to every 5 years (after initial 2-year report), reducing oversight frequency but allowing program time to show impact before evaluation.
• Explicit equity and disparities-reduction language may increase administrative burden on state programs to track and report on health-equity outcomes, though no new compliance mechanism is specified.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill directly expands access to cancer screening for uninsured and underinsured women, a population with documented health disparities. It adds explicit focus on equity, disparities reduction, and removal of access barriers—all public-health gains with no offsetting cost to citizens.

Named in the bill

National Breast and Cervical Cancer Early Detection Program (NBCCEDP), Public Health Service Act, Centers for Disease Control and Prevention (implied administrator), U.S. Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce, Government Accountability Office (GAO)

Where it stands

71 cosponsors: 54 Democrats, 17 Republicans.

• Mar 26, 2025 — Introduced · Congress.gov: “Introduced in House”
• Mar 26, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

3 lobbying clients named this bill on 3 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $520,000 in lobbying spend. A filing names 16 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 61% of bills with at least one filing.

Joseph Morelle, the sponsor, reported $934,875 in PAC receipts in the 2026 cycle. $1,000 of that came from 1 PAC tied to these lobbying clients.

• GE Healthcare Technologies Inc. — $350,000 on 1 filing
• The Susan G. Komen Breast Cancer Foundation, Inc. Dba Susan G. Komen — $130,000 on 1 filing
• Susan G. Komen — $40,000 on 1 filing

Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.